Title : Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial - Consolim-Colombo_2017_JCI.Insight_2_ |
Author(s) : Consolim-Colombo FM , Sangaleti CT , Costa FO , Morais TL , Lopes HF , Motta JM , Irigoyen MC , Bortoloto LA , Rochitte CE , Harris YT , Satapathy SK , Olofsson PS , Akerman M , Chavan SS , MacKay M , Barnaby DP , Lesser ML , Roth J , Tracey KJ , Pavlov VA |
Ref : JCI Insight , 2 : , 2017 |
Abstract : Consolim-Colombo_2017_JCI.Insight_2_ |
ESTHER : Consolim-Colombo_2017_JCI.Insight_2_ |
PubMedSearch : Consolim-Colombo_2017_JCI.Insight_2_ |
PubMedID: 28724799 |
Consolim-Colombo FM, Sangaleti CT, Costa FO, Morais TL, Lopes HF, Motta JM, Irigoyen MC, Bortoloto LA, Rochitte CE, Harris YT, Satapathy SK, Olofsson PS, Akerman M, Chavan SS, MacKay M, Barnaby DP, Lesser ML, Roth J, Tracey KJ, Pavlov VA (2017)
Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial
JCI Insight
2 :
Consolim-Colombo FM, Sangaleti CT, Costa FO, Morais TL, Lopes HF, Motta JM, Irigoyen MC, Bortoloto LA, Rochitte CE, Harris YT, Satapathy SK, Olofsson PS, Akerman M, Chavan SS, MacKay M, Barnaby DP, Lesser ML, Roth J, Tracey KJ, Pavlov VA (2017)
JCI Insight
2 :